Toral Patel, M.D. - Faculty Profile - UT Southwestern
Education
Medical School
UT Southwestern Medical School (2006)
Internship
Yale New Haven Hospital (2007), General Surgery
Residency
Yale New Haven Hospital (2013), Neurological Surgery
Fellowship
Memorial Sloan Kettering Cancer Institute (2014), Neuro-oncology
Publications
Magnetic Resonance Spectroscopy of Cystathionine and 2-Hydroxyglutarate in Brain Tumors
Choi C, Huynh M, Kovacs Z, Behof W, Pham W, Ganji S, An Z, Patel T, Maher E, Berry J, Mobley B, Davis L, McKnight C, Pruthi S, Merrell R, Mohler A, Kelly P, Thompson R
NMR in biomedicine
2026 Jan 39
Categorical and phenotypic image synthetic learning as an alternative to federated learning
Truong NC, Bangalore Yogananda CG, Wagner BC, Holcomb JM, Reddy DD, Saadat N, Bowerman J, Hatanpaa KJ, Patel TR, Fei B, Lee MD, Jain R, Bruce RJ, Madhuranthakam AJ, Pinho MC, Maldjian JA
Nature communications
2025 Dec 16
Tumor control following gamma knife radiosurgery for parasagittal meningiomas: a single institution retrospective analysis
Ebada A, Bever N, Shukla IY, Traylor JI, Wan B, Timmerman RD, Dohopolski M, De Vis J, Patel T, Patel A, Barnett SL, Wardak Z, Dan T, Sun MZ
Clinical Neurology and Neurosurgery
2025 Dec 259
Convection enhanced delivery of Rhenium (
186
Re) Obisbemeda (
186
RNL) in recurrent glioma: a multicenter, single arm, phase 1 clinical trial
Brenner AJ, Patel T, Bao A, Phillips WT, Michalek JE, Youssef M, Weinberg JS, Kamiya Matsuoka C, Hedrick MH, LaFrance N, Moore M, Floyd JR
Nature communications
2025 Dec 16
Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate and Glycine in Adult Subjects With Brainstem Gliomas
Tiwari V, Ganji S, An Z, Pinho M, Davis L, McKnight C, Berry J, Mobley B, Luo L, Mohler A, Merrell R, Kelly P, Thompson R, Mickey B, Malloy C, Gore J, Patel T, Maher E, Choi C
NMR in biomedicine
2025 Nov 38
TE optimization for J-difference editing of 2-hydroxyglutarate at 3T
Chan KL, Hapani R, Maher EA, Patel TR, Henning A
Magnetic resonance in medicine
2025 Oct 94 1363-1376
Comparative Outcomes of Standard Radiation Therapy and 5-Fraction Adaptive Stereotactic Radiation Therapy in Newly Diagnosed Glioblastoma: A Propensity Score–Matched Analysis
Dohopolski M, Schmitt LG, de Vis J, Mostardeiro TR, Anand S, Youssef M, Noch E, Maher E, Sun M, Patel T, Patel A, Barnett S, Lee MJ, Iakovenko V, Chiu T, Su FC, Pompos A, Lin MH, Cai X, Timmerman R, Dan T, Wardak Z
Advances in Radiation Oncology
2025 Aug 10
Exploratory Evaluation of Personalized Ultrafractionated Stereotactic Adaptive Radiation Therapy (PULSAR) With Central Nervous System-Active Drugs in Brain Metastases Treatment
Dohopolski M, Schmitt LG, Anand S, Zhang H, Stojadinovic S, Youssef M, Shaikh N, Patel T, Patel A, Barnett S, Lee DS, Ahn C, Lee MJ, Timmerman R, Peng H, Cai X, Dan T, Wardak Z
International Journal of Radiation Oncology Biology Physics
2025 Jul 122 611-620
Standard Dose Versus Reduced Dose Single Fraction Preoperative Radiosurgery for Resected Brain Metastases (PROPS-BM) International Multicenter Cohort Study
Prabhu RS, Russek R, Vaslow ZK, Matsui JK, Haghighi N, Dan T, Mishra MV, Murphy ES, Boyles S, Perlow HK, Palmer JD, Udovicich C, Patel TR, Wardak Z, Woodworth GF, Ksendzovsky A, Yang K, Chao ST, Asher AL, Burri SH
Advances in Radiation Oncology
2025 Jul 10
Bridging the clinical gap: Confidence informed IDH prediction in brain gliomas using MRI and deep learning
Bangalore Yogananda CG, Truong NC, Wagner BC, Xi Y, Bowerman J, Reddy DD, Holcomb JM, Saadat N, Hatanpaa KJ, Patel TR, Fei B, Lee MD, Jain R, Bruce RJ, Madhuranthakam AJ, Pinho MC, Maldjian JA
Neuro-Oncology Advances
2025 Jan 7
Quick Links
Administrative Offices
UTSW Leadership